Hydroxychloroquine questions intensify as journal says its drug study "did not meet expected standards"
— Elisabeth Bik (@MicrobiomDigest) April 7, 2020
Shortly after publication, scientists ...began to point out flaws in the research that cast doubt on the study. On March 24, Bik published a long list. https://t.co/rrJ5GpZQKU